JMDC Inc
TSE:4483

Watchlist Manager
JMDC Inc Logo
JMDC Inc
TSE:4483
Watchlist
Price: 3 365 JPY 0.3% Market Closed
Market Cap: ¥220.2B

JMDC Inc
Free Cash Flow

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

JMDC Inc
Free Cash Flow Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Free Cash Flow CAGR 3Y CAGR 5Y CAGR 10Y
JMDC Inc
TSE:4483
Free Cash Flow
¥7.1B
CAGR 3-Years
54%
CAGR 5-Years
220%
CAGR 10-Years
N/A
M3 Inc
TSE:2413
Free Cash Flow
¥53.1B
CAGR 3-Years
2%
CAGR 5-Years
7%
CAGR 10-Years
19%
S
Software Service Inc
TSE:3733
Free Cash Flow
¥2.8B
CAGR 3-Years
50%
CAGR 5-Years
17%
CAGR 10-Years
35%
Medley Inc
TSE:4480
Free Cash Flow
¥3B
CAGR 3-Years
22%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
CareNet Inc
TSE:2150
Free Cash Flow
¥2B
CAGR 3-Years
15%
CAGR 5-Years
31%
CAGR 10-Years
21%
Medical Data Vision Co Ltd
TSE:3902
Free Cash Flow
¥719.8m
CAGR 3-Years
-6%
CAGR 5-Years
-5%
CAGR 10-Years
N/A
No Stocks Found

JMDC Inc
Glance View

Market Cap
220.2B JPY
Industry
Health Care

Amidst the complex intersection of healthcare and technology, JMDC Inc. has carved a unique niche by harnessing the power of big data to improve healthcare outcomes and efficiency. Founded in Japan, the company stands as a beacon in the health informatics sector, meticulously collecting and analyzing health-related data drawn from a variety of sources, including medical claims, health screenings, and electronic health records. By transforming this extensive data trove into actionable insights, JMDC offers healthcare providers, pharmaceutical companies, and insurance firms the analytics they need to make informed decisions. Key to JMDC's operation is its commitment to safeguarding patient anonymity while extracting valuable insights that can streamline healthcare delivery, enhance pharmaceutical research, and optimize insurance underwriting. JMDC's revenue model hinges on the sale of its aggregated data and analytics solutions to a vast array of stakeholders in the medical field. Pharmaceutical companies, eager to understand drug efficacy and patient demographics better, turn to JMDC for data-driven insights that can influence drug development and marketing strategies. Insurance companies leverage JMDC's data to refine their offerings and better assess risk, ensuring competitive pricing models and improved customer satisfaction. Moreover, healthcare providers utilize this analytics backbone to enhance operational efficiency and improve patient care outcomes. Through licensing agreements and subscription-based services, JMDC effectively monetizes its data resources, achieving sustained growth in an industry that increasingly values the marriage of technology and healthcare.

Intrinsic Value
3 968.52 JPY
Undervaluation 15%
Intrinsic Value
Price ¥3 365

See Also

What is JMDC Inc's Free Cash Flow?
Free Cash Flow
7.1B JPY

Based on the financial report for Dec 31, 2025, JMDC Inc's Free Cash Flow amounts to 7.1B JPY.

What is JMDC Inc's Free Cash Flow growth rate?
Free Cash Flow CAGR 5Y
220%

Over the last year, the Free Cash Flow growth was 12%. The average annual Free Cash Flow growth rates for JMDC Inc have been 54% over the past three years , 220% over the past five years .

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett